A new microfluidic method for evaluating drugs commonly used
for preventing heart attacks has found that while aspirin can prevent dangerous
blood clots in some at-risk patients, it may not be effective in all patients
with narrowed arteries. The study, which involved 14 human subjects, used a
device that simulated blood flowing through narrowed coronary arteries to
assess effects of anti-clotting drugs.